NDC 0074-1043 – Rinvoq
Upadacitinib 45 mg/1 · Tablet, Extended Release · Oral
Product NDC0074-1043
Product details
- Brand name
- Rinvoq
- Generic name
- Upadacitinib
- Labeler
- AbbVie Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA211675
- Marketed since
- August 16, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Janus Kinase Inhibitor
Active ingredients
- Upadacitinib 45 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0074-1043-14 sample | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-14) | Mar 16, 2022 |
| 0074-1043-28 | 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-28) | Mar 16, 2022 |